Original Research

Cost-effectiveness of Tamoxifen, Aromatase Inhibitor, and Switch Therapy (Adjuvant Endocrine Therapy) for Breast Cancer in Hormone Receptor Positive Postmenopausal Women in India

Butani D, Gupta N, Jyani G, Bahuguna P, Kapoor R, Prinja S

Breast Cancer: Targets and Therapy 2021, 13:625-640

Published Date: 27 November 2021